Market revenue in 2023 | USD 368.4 million |
Market revenue in 2030 | USD 861.2 million |
Growth rate | 12.9% (CAGR from 2023 to 2030) |
Largest segment | Conventional blood culture technique |
Fastest growing segment | Automated blood culture technique |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Conventional blood culture technique, Automated blood culture technique |
Key market players worldwide | BD, Terumo Corp, Bruker Corp, BioMerieux SA, Luminex, Abbott Laboratories, Siemens Healthineers AG ADR, Danaher Corp, Roche, T2 Biosystems Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood culture test market will help companies and investors design strategic landscapes.
Conventional blood culture technique was the largest segment with a revenue share of 64.93% in 2023. Horizon Databook has segmented the Japan blood culture test market based on conventional blood culture technique, automated blood culture technique covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan blood culture test market , including forecasts for subscribers. This country databook contains high-level insights into Japan blood culture test market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account